Top

Published in:

01-11-2003 | Original

A 7-year study of severe hospital-acquired pneumonia requiring ICU admission

Authors: Jordi Vallés, Eduard Mesalles, Dolors Mariscal, Ma del Mar Fernández, Rocío Peña, José Luis Jiménez, Jordi Rello

Published in: Intensive Care Medicine | Issue 11/2003

Abstract

Objective

To examine the characteristics, prognostic factors, and outcome of patients with severe hospital-acquired pneumonia admitted to the ICU.

Design and setting

Prospective observational clinical study in two medical-surgical ICUs with 16 and 20 beds

Patients and participants

During a 7-year period all hospitalized patients requiring admission to either ICU for hospital-acquired pneumonia were followed up.

Measurements and results

We diagnosed 96 episodes of severe hospital-acquired pneumonia, and in 67 cases a causal diagnosis was made. Most episodes were late-onset pneumonia. Gram-negative micro-organisms were isolated in 51% of episodes diagnosed, and Pseudomonas aeruginosa was the most frequent pathogen isolated (24%). Clearly significant variations happened between hospitals, particularly affecting the incidence of Aspergillus spp. and Legionella pneumophila. Forty-nine patients developed septic shock (51%). Fifty-one patients died (53%). Aspergillosis and pneumonia due to P. aeruginosa were associated with the highest mortality. Septic shock (OR: 14.27) and chronic obstructive pulmonary disease (OR: 6.11) were independently associated with a poor prognosis.

Conclusions

Patients with severe hospital-acquired pneumonia admitted to the ICU present high mortality. The presence of septic shock and chronic obstructive pulmonary disease in conjunction with specific microorganisms are associated with a poor prognosis. Local epidemiological data combined with a patient-based approach may allow a more accurate therapy decision making.

Craven DE, Steger KA, Barber TW (1991) Preventing nosocomial pneumonia: state of the art and perspectives for the 1990's. Am J Med 91:44S–53SPubMed

Gross PA, Van Antwerpen C (1983) Nosocomial infections and hospital deaths: a case-control study. Am J Med 75:658–662PubMed

Gross PA, New HC, Aswapokee P, Van Antwerpen C, Aswapokee N (1980) Deaths from nosocomial infections: experience in a university hospital and a community hospital. Am J Med 68:219–223PubMed

McEachern R, Campbell GD Jr (1998) Hospital-acquired pneumonia: epidemiology, etiology, and treatment. Infect Dis Clin North Am 12:761–779PubMed

Mayhall CG (1997) Nosocomial pneumonia: diagnosis and prevention. Infect Dis Clin North Am 11:427–457PubMed

American Thoracic Society (1996) Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies. Am J Respir Crit Care Med 153:1711–1725PubMed

Craven DE, Driks MR (1987) Pneumonia in the intubated patient. Semin Respir Infect 2:20–33PubMed

Celis R, Torres A, Gatell JM, Almela M, Rodriguez-Roisin R, Agusti-Vidal A (1988) Nosocomial pneumonia: a multivariate analysis of risk and prognosis. Chest 93:318–324PubMed

Fagon GY, Chastre J, Hance A, Montravers P, Novara A, Gibert C (1993) Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 94:281–288PubMed

10.

Fagon GY, Chastre J, Domart Y, Trouillet JL, Pierre J, Carne C, Gibert C (1989) Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 139:877–884PubMed

11.

Rello J, Jubert P, Vallés J, Artigas A, Rue M, Niederman MS (1996) Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa. Clin Infect Dis 23:973–978PubMed

12.

Timsit JF, Chevret S, Valcke J, Misset B, Renaud B, Goldstein FW, Vaury P, Carlet J (1996) Mortality of nosocomial pneumonia in ventilated patients: influence of diagnostic tools. Am J Respir Crit Care Med 154:116–123PubMed

13.

Heyland D, Cook D, Griffith L, Keenan SP, Brun-Buisson C (1999) The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. Am J Respir Crit Care Med 159:1249–1256PubMed

14.

Haley RW, Hooton TM, Culver DH, Stanley RC, Emori TG (1981) Nosocomial infections in U.S. hospitals, 1975–1976. Am J Med 70:947–959PubMed

15.

Hughees JM, Culver DH, White JW, Jarvis WR, Munn VP, Mosser JL, Emori TG (1983) Nosocomial infection surveillance, 1980–1982. MMWR 32 (4SS):1SS-15SS

16.

Leu H, Kaiser DL, Mori M, Woolson RF, Wenzel RP (1989) Hospital-acquired pneumonia. Attributable mortality and morbidity. Am J Epidemiol 129:1258–1267PubMed

17.

Richards M, Edwards J, Culver D, Gaynes RP (1999) Nosocomial infections in medical intensive care units in the United States. Crit Care Med 27:887–892PubMed

18.

NNIS System (1999) National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control 27:520–532PubMed

19.

Tablan O, Anderson L, Arden NH, Breiman RF, Butler JC, McNeil MM (1994) Guidelines for prevention of nosocomial pneumonia. Am J Infect Control 22:247–292PubMed

20.

Friedman L, Niederman MS, Chalfin DB, Flaster E, Fein AM (1994) Use of a prognostic scoring index to accurately predict survival from severe pneumonia. Am J Respir Crit Care Med 149:A806

21.

Cassiere HA, Fein MA (1996) Severe community-acquired pneumonia. Curr Opin Pulm Med 2:186–191PubMed

22.

Leeper KV (1996) Severe community-acquired pneumonia. Semin Respir Infect 11:96–108PubMed

23.

Leroy O, Santre C, Beuscart C, Georges H, Guery B, Jacquier JM, Beaucaire G (1995) A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intensive Care Med 21:24–31PubMed

24.

Ewig S, Ruiz M, Mensa J, Marcos MA, Martinez JA, Arancibia F, Niederman MS, Torres A (1998) Severe community-acquired pneumonia. Assessment of severity criteria. Am J Respir Crit Care Med 158:1102–1108PubMed

25.

Hirani NA, Macfarlane JT (1997) Impact of management guidelines on the outcome of severe community-acquired pneumonia. Thorax 52:17–21PubMed

26.

Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336:243–250PubMed

27.

American Thoracic Society (1993) Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 148:1418–1426PubMed

28.

Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818–829PubMed

29.

Vallés J, Leon C, Alvarez F, and Spanish Collaborative Group for Infections in ICUs (1997) Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis. Clin Infect Dis 24:387–395PubMed

30.

Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101:1644–1655PubMed

31.

Pauwels RA, Buist AS, Calverley PMA, Jenkins CR, Hurd SJ (2001) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med 163:1256–1276PubMed

32.

Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, LeGall JR, Morris A, Spragg R (1994) Report of the American-European consensus coonference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. Intensive Care Med 20:225–232PubMed

33.

Denning DW, Lee JY, Hostetler JS, Pappas P, Kauffman CA, Dewsnup DH, Galgiani JN, Graybill JR, Sugar AM, Catanzaro A (1994) NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis. Am J Med 97:135–144

34.

Meduri GU, Chastre J (1992) The standardization of bronchoscopic techniques for ventilator-associated pneumonia. Chest 102:557S-564SPubMed

35.

Murray PR, Washington JA II (1975) Microscopic and bacteriologic analysis of expectorated sputum. Mayo Clin Proc 50:339–344PubMed

36.

Fisher LlD, Van Belle G (1993) Biostatistics: a methodology for the health sciences. In: Fisher LlD, Van Belle (ed) Wiley, New York, pp 496–595

37.

Hosmer DW Jr, Lemeshow S (1989) Applied logistic regression. In: Hosmer DW, Lemeshow S (ed) Wiley, New York, pp 82–134

38.

Rello J, Esandi ME, Mariscal D, Gallego M, Domingo C, Vallés J (1998) Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review. Clin Infect Dis 26:1473–1475PubMed

39.

Carratalá J, Gudiol F, Pallarés R, Dorca J, Verdaguer R, Ariza J, Manresa F (1994) Risk factors for nosocomial Legionella pneumophila pneumonia. Am J Respir Crit Care Med 149:625–629PubMed

40.

Rodrigues J, Niederman MS, Fein AM, Pai PB (1992) Nonresolving pneumonia in steroid-treated patients with obstructive lung disease. Am J Med 93:29–34

41.

Crean JM, Niederman MS, Fein AM, Feinsilver SH (1992) Rapidily progressive respiratory failure due to Aspergillus pneumonia: a complication of short-term corticosteroid therapy. Crit Care Med 20:148–150PubMed

42.

Stout JE, Yu VL, Vickers RM, Zuravleff J, Best M, Brown A, Yee RB, Wadowsky R (1982) Ubiquitousness of Legionella pneumophila in the water suply of a hospital with endemic Legionnaires' disease. N Engl J Med 306:466–468PubMed

43.

Kirby BD, Snyder KM, Meyer RD, Finegold SM (1978) Legionnaires' disease: clinical features of 24 cases. Ann Intern Med 89:297–309

44.

Tobin JO (1980) Legionnaires' disease in a transplant unit: isolation of the causative agent from shower baths. Lancet II:118–121

45.

Rello J, Quintana E, Ausina V, Puzo C, Net A, Prats G (1990) Risk factors for Staphylococcus aureus nosocomial pneumonia in critically ill patients. Am Rev Respir Dis 142:1320–1324PubMed

46.

Rello J, Torres A, Ricart M, Vallés J, González J, Artigas A, Rodríguez-Roisín R (1994) Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med 150:1545–1549PubMed

47.

Pujol M, Corbella X, Peña C, Pallarés, R, Dorca J, Verdaguer R, Díaz-Prieto A, Ariza J, Gudiol F (1998) Clinical and epidemiological findings in mechanically ventilated patients with methicillin-resistant Staphylococcus aureus pneumonia. Eur J Clin Microbiol Infect Dis 17:622–628CrossRefPubMed

48.

Pachón J, Prados MD, Capote F, Cuello JA, Garnacho J, Verano A (1990) Severe community-acquired pneumonia. Etiology, prognosis, and treatment. Am Rev Respir Dis 142:369–373PubMed

49.

Rello J, Quintana E, Ausina V, Net A, Prats G (1993) A three-year study of severe community-acquired pneumonia with emphasis on outcome. Chest 103:232–235PubMed

50.

Annane D, Sebille V, Charpentier C, Bollaert PE, François B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, Chaumet-Riffaut P, Bellisant E (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862–871PubMed

Title: A 7-year study of severe hospital-acquired pneumonia requiring ICU admission
Authors: Jordi Vallés
Eduard Mesalles
Dolors Mariscal
Ma del Mar Fernández
Rocío Peña
José Luis Jiménez
Jordi Rello
Publication date: 01-11-2003
Publisher: Springer-Verlag
Published in: Intensive Care Medicine / Issue 11/2003
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-003-2008-4

At a glance: The STEP trials

Springer Medicine

A 7-year study of severe hospital-acquired pneumonia requiring ICU admission

Abstract

Objective

Design and setting

Patients and participants

Measurements and results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Objective

Design and setting

Patients and participants

Measurements and results

Conclusions

Please log in to get access to this content

Other articles of this Issue 11/2003

Death by parenteral nutrition

Early patterns of static pressure–volume loops in ARDS and their relations with PEEP-induced recruitment

Is parenteral nutrition guilty?

Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery

PEEP decreases atelectasis and extravascular lung water but not lung tissue volume in surfactant-washout lung injury

Triggering and cycling off during pressure support ventilation: simplicity or sophistication?